检索结果 - Hiroko Asanuma
- Showing 1 - 20 results of 20
-
1
Survivin Expression Is Regulated by Coexpression of Human Epidermal Growth Factor Receptor 2 and Epidermal Growth Factor Receptor via Phosphatidylinositol 3-Kinase/AKT Signaling Pa... 由 Hiroko Asanuma, Toshihiko Torigoe, Kenjiro Kamiguchi, Yoshihiko Hirohashi, Tousei Ohmura, Koichi Hirata, Masaaki Sato, Noriyuki Sato
出版 2005Artigo -
2
-
3
Prognostic impact of the expression of ALDH1 and SOX2 in urothelial cancer of the upper urinary tract 由 Hiroshi Kitamura, Toshihiko Torigoe, Yoshihiko Hirohashi, Hiroko Asanuma, Ryuta Inoue, Sachiyo Nishida, Toshiaki Tanaka, Fumimasa Fukuta, Naoya Masumori, Noriyuki Sato, Taiji Tsukamoto
出版 2012Artigo -
4
Ovarian Cancer Stem Cells Are Enriched in Side Population and Aldehyde Dehydrogenase Bright Overlapping Population 由 Kazuyo Yasuda, Toshihiko Torigoe, Rena Morita, Takahumi Kuroda, Akari Takahashi, Junichi Matsuzaki, Vitaly Kochin, Hiroko Asanuma, Tadashi Hasegawa, Tsuyoshi Saito, Yoshihiko Hirohashi, Noriyuki Sato
出版 2013Artigo -
5
ALDH1-High Ovarian Cancer Stem-Like Cells Can Be Isolated from Serous and Clear Cell Adenocarcinoma Cells, and ALDH1 High Expression Is Associated with Poor Prognosis 由 Takafumi Kuroda, Yoshihiko Hirohashi, Toshihiko Torigoe, Kazuyo Yasuda, Akari Takahashi, Hiroko Asanuma, Rena Morita, Tasuku Mariya, Takuya Asano, Masahito Mizuuchi, Tsuyoshi Saito, Noriyuki Sato
出版 2013Artigo -
6
Prognostic significance of HLA class I expression in osteosarcoma defined by anti‐pan HLA class I monoclonal antibody, EMR8‐5 由 Tomohide Tsukahara, Satoshi Kawaguchi, Toshihiko Torigoe, Hiroko Asanuma, Emiri Nakazawa, Kumiko Shimozawa, Yuki Nabeta, Shigeharu Kimura, Mitsunori Kaya, Satoshi Nagoya, Takuro Wada, Toshihiko Yamashita, Noriyuki Sato
出版 2006Artigo -
7
Phase I clinical trial of survivin‐derived peptide vaccine therapy for patients with advanced or recurrent oral cancer 由 Akihiro Miyazaki, Jun’ichi Kobayashi, Toshihiko Torigoe, Yoshihiko Hirohashi, Takashi Yamamoto, Akira Yamaguchi, Hiroko Asanuma, Akari Takahashi, Yoshitaka Michifuri, Kenji Nakamori, Itaru NAGAI, Noriyuki Sato, Hiroyoshi Hiratsuka
出版 2010Artigo -
8
SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity 由 Munehide Nakatsugawa, Akari Takahashi, Yoshihiko Hirohashi, Toshihiko Torigoe, Satoko Inoda, Masaki Murase, Hiroko Asanuma, Yasuaki Tamura, Rena Morita, Yoshitaka Michifuri, Tôru Kondo, Tadashi Hasegawa, Hiroki Takahashi, Noriyuki Sato
出版 2011Artigo -
9
Fibroblasts induce expression of FGF4 in ovarian cancer stem-like cells/cancer-initiating cells and upregulate their tumor initiation capacity 由 Kazuyo Yasuda, Toshihiko Torigoe, Tasuku Mariya, Takuya Asano, Takafumi Kuroda, Junichi Matsuzaki, Kanae Ikeda, M. Yamauchi, Makoto Emori, Hiroko Asanuma, Tadashi Hasegawa, Tsuyoshi Saito, Yoshihiko Hirohashi, Noriyuki Sato
出版 2014Artigo -
10
Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy 由 Takuya Asano, Yoshihiko Hirohashi, Toshihiko Torigoe, Tasuku Mariya, Ryota Horibe, Takafumi Kuroda, Yuta Tabuchi, Hiroshi Saijo, Kazuyo Yasuda, Masahito Mizuuchi, Akari Takahashi, Hiroko Asanuma, Tadashi Hasegawa, Tsuyoshi Saito, Noriyuki Sato
出版 2016Artigo -
11
Cytotoxic T Lymphocytes Efficiently Recognize Human Colon Cancer Stem-Like Cells 由 Satoko Inoda, Yoshihiko Hirohashi, Toshihiko Torigoe, Rena Morita, Akari Takahashi, Hiroko Asanuma, Munehide Nakatsugawa, Satoshi Nishizawa, Yasuaki Tamura, Tetsuhiro Tsuruma, Takeshi Terui, Tôru Kondo, Kunihiko Ishitani, Tadashi Hasegawa, Koichi Hirata, Noriyuki Sato
出版 2011Artigo -
12
Aberrant Expression and Potency as a Cancer Immunotherapy Target of Inhibitor of Apoptosis Protein Family, Livin/ML-IAP in Lung Cancer 由 Hiroyuki Hariu, Yoshihiko Hirohashi, Toshihiko Torigoe, Hiroko Asanuma, Midori Hariu, Yasuaki Tamura, Katsuyuki Aketa, Chika Nabeta, Katsuya Nakanishi, Kenjiro Kamiguchi, Yoshinori Mano, Hiroshi Kitamura, Jun’ichi Kobayashi, Tomohide Tsukahara, Noriharu Shijubo, Noriyuki Sato
出版 2005Artigo -
13
Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma. 由 Satoshi Kawaguchi, Takuro Wada, Kazunori Ida, Yuriko Sato, Satoshi Nagoya, Tomohide Tsukahara, Sigeharu Kimura, Hiroeki Sahara, Hideyuki Ikeda, Kumiko Shimozawa, Hiroko Asanuma, Toshihiko Torigoe, Hiroaki Hiraga, Takeshi Ishii, Shin‐ichiro Tatezaki, Noriyuki Sato, Toshihiko Yamashita
出版 2005Artigo -
14
Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer 由 Tetsuhiro Tsuruma, Yuji Iwayama, Tosei Ohmura, Tadashi Katsuramaki, Fumitake Hata, Tomohisa Furuhata, Koji Yamaguchi, Yasutoshi Kimura, Toshihiko Torigoe, Nobuhiko TOYOTA, Atsuhito Yagihashi, Yoshihiko Hirohashi, Hiroko Asanuma, Kumiko Shimozawa, M. Okazaki, Yasuhiro Mizushima, Naohiro Nomura, Noriyuki Sato, Koichi Hirata
出版 2008Artigo -
15
HSP DNAJB8 Controls Tumor-Initiating Ability in Renal Cancer Stem–like Cells 由 Satoshi Nishizawa, Yoshihiko Hirohashi, Toshihiko Torigoe, Akari Takahashi, Yasuaki Tamura, Takashi Mori, Takayuki Kanaseki, Kenjiro Kamiguchi, Hiroko Asanuma, Rena Morita, Alice Sokolovskaya, Junichi Matsuzaki, Ren Yamada, Reona Fujii, Harm H. Kampinga, Tôru Kondo, Tadashi Hasegawa, Isao Hara, Noriyuki Sato
出版 2012Artigo -
16
High Expression of CD109 Antigen Regulates the Phenotype of Cancer Stem-Like Cells/Cancer-Initiating Cells in the Novel Epithelioid Sarcoma Cell Line ESX and Is Related to Poor Pro... 由 Makoto Emori, Tomohide Tsukahara, Masaki Murase, Masanobu Kano, Kenji Murata, Akari Takahashi, Terufumi Kubo, Hiroko Asanuma, Kazuyo Yasuda, Vitaly Kochin, Mitsunori Kaya, Satoshi Nagoya, Jun Nishio, Hiroshi Iwasaki, Tomoko Sonoda, Tadashi Hasegawa, Toshihiko Torigoe, Takuro Wada, Toshihiko Yamashita, Noriyuki Sato
出版 2013Artigo -
17
A Potent Immunogenic General Cancer Vaccine That Targets Survivin, an Inhibitor of Apoptosis Proteins 由 Satomi Idenoue, Yoshihiko Hirohashi, Toshihiko Torigoe, Yuriko Sato, Yasuaki Tamura, Hiroyuki Hariu, Masaaki Yamamoto, Takehiro Kurotaki, Tetsuhiro Tsuruma, Hiroko Asanuma, Takayuki Kanaseki, Hideyuki Ikeda, Kiyoteru Kashiwagi, M. Okazaki, Kazuaki Sasaki, Takashi Sato, Tousei Ohmura, Fumitake Hata, Koji Yamaguchi, Koichi Hirata, Noriyuki Sato
出版 2005Artigo -
18
Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer. 由 Tetsuhiro Tsuruma, Fumitake Hata, Toshihiko Torigoe, Tomohisa Furuhata, Satomi Idenoue, Takehiro Kurotaki, Masaaki Yamamoto, Atsuhito Yagihashi, Tosei Ohmura, Koji Yamaguchi, Tadashi Katsuramaki, Takahiro Yasoshima, Kazuaki Sasaki, Yasuhiro Mizushima, Hidetoshi MINAMIDA, Hiromichi Kimura, Morifumi Akiyama, Yoshihiko Hirohashi, Hiroko Asanuma, Yasuaki Tamura, Kumiko Shimozawa, Noriyuki Sato, Koichi Hirata
出版 2004Artigo -
19
Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer–Initiating Cells and Is a Potent Target of Immunotherapy 由 Rena Morita, Yoshihiko Hirohashi, Toshihiko Torigoe, Satoko Ito-Inoda, Akari Takahashi, Tasuku Mariya, Hiroko Asanuma, Yasuaki Tamura, Tomohide Tsukahara, Takayuki Kanaseki, Terufumi Kubo, Goro Kutomi, Toru Mizuguchi, Takeshi Terui, Kunihiko Ishitani, Satoshi Hashino, Tôru Kondo, Nozomi Minagawa, Norihiko Takahashi, Akinobu Taketomi, Satoru Todo, Masahiro Asaka, Noriyuki Sato
出版 2016Artigo -
20
Randomized phase <scp>II</scp> trial of survivin 2B peptide vaccination for patients with <scp>HLA</scp>‐A24‐positive pancreatic adenocarcinoma 由 Hiroaki Shima, Giichiro Tsurita, Satoshi Wada, Yoshihiko Hirohashi, Hiroshi Yasui, Hiroshi Hayashi, Takashi Miyakoshi, Kazue Watanabe, Aiko Murai, Hiroko Asanuma, Serina Tokita, Terufumi Kubo, Munehide Nakatsugawa, Takayuki Kanaseki, Tomohide Tsukahara, Yutaka Nakae, Osamu Sugita, Yoichi M. Ito, Yasunori Ota, Yasutoshi Kimura, Goro Kutomi, Koichi Hirata, Toru Mizuguchi, Kohzoh Imai, Ichiro Takemasa, Noriyuki Sato, Toshihiko Torigoe
出版 2019Artigo
相关主题
Biology
Medicine
Cancer
Cancer research
Biochemistry
Internal medicine
Genetics
Immunology
Pathology
Antigen
CD8
Gene
Cancer stem cell
Epitope
Immunotherapy
Stem cell
CTL*
Cell biology
Environmental health
In vitro
Oncology
Peptide vaccine
Population
Immune system
SOX2
Survivin
Vaccination
Cancer cell
Cell culture
Cytotoxic T cell